Peptic ulcer disease, Helicobacter pylori infection and chronic gastritis – Related resources
22.09.2014 • Sonuncu dəyişiklik 15.03.2010
This article is created and updated by the EBMG Editorial Team
Cochrane reviews
- High dose and medium to low dose proton pump inhibitors may be equally effective in the treatment of acute peptic ulcer bleeding .
Other Evidence summaries
Ranitidine bismuth citrate in conjunction with chlarithromycin has achieved Helicobacter pylori eradication rates above 80% and ulcer healing rates above 70% .
Literature
Clinical practice reviews
McColl KE. Clinical practice. Helicobacter pylori infection. N Engl J Med 2010 Apr 29;362(17):1597-604. - Luther J, Higgins PD, Schoenfeld PS, Moayyedi P, Vakil N, Chey WD. Empiric quadruple vs. triple therapy for primary treatment of Helicobacter pylori infection: Systematic review and meta-analysis of efficacy and tolerability. Am J Gastroenterol 2010 Jan;105(1):65-73.
- Malfertheiner P, Chan FK, McColl KE. Peptic ulcer disease. Lancet 2009 Oct 24;374(9699):1449-61.
- Fuccio L, Laterza L, Zagari RM, Cennamo V, Grilli D, Bazzoli F. Treatment of Helicobacter pylori infection. BMJ 2008 Sep 15;337():a1454.
- Shah R. Dyspepsia and Helicobacter pylori. BMJ 2007 Jan 6;334(7583):41-3.
- Chan FK, Wong VW, Suen BY, Wu JC, Ching JY, Hung LC, Hui AJ, Leung VK, Lee VW, Lai LH, Wong GL, Chow DK, To KF, Leung WK, Chiu PW, Lee YT, Lau JY, Chan HL, Ng EK, Sung JJ. Combination of a cyclo-oxygenase-2 inhibitor and a proton-pump inhibitor for prevention of recurrent ulcer bleeding in patients at very high risk: a double-blind, randomised trial. Lancet 2007 May 12;369(9573):1621-6.